Ovid Therapeutics Inc. (OVID)
NASDAQ · Healthcare
Ovid Therapeutics Inc. annual/quarterly cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Ovid Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 13.2M, a 49.99% decrease year-over-year.
- Ovid Therapeutics Inc. cash on hand for 2025 were 13.2M, a 49.99% decrease from 2024.
- Ovid Therapeutics Inc. cash on hand for 2024 were 26.3M, a 2.74% decrease from 2023.
- Ovid Therapeutics Inc. cash on hand for 2023 were 27.0M, a 39.73% decrease from 2022.
- Ovid Therapeutics Inc. cash on hand for 2022 were 44.9M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Ovid Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $13 |
| 2024 | $26 |
| 2023 | $27 |
| 2022 | $45 |
| 2021 | $188 |
| 2020 | $72 |
| Ovid Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $13 |
| 2024-12-31 | $26 |
| 2023-12-31 | $27 |
| 2022-12-31 | $45 |
| 2021-12-31 | $188 |
| 2020-12-31 | $72 |
Ovid Therapeutics Inc. Cash on Hand — FAQ
Ovid Therapeutics Inc. (OVID) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OVID's cash on hand history?
The chart and table above show Ovid Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.